Before the COVID-19 pandemic, the combined market cap of Teladoc and Livongo was about $10 billion. Now that they are merging together in a deal announced earlier this week, the new company will have an estimated value of close to $40 billion.
Why has the value of these healthcare companies jumped so much and is this deal good news for investors?
In this episode of Stock Club, we also discuss:
Don’t miss out on the upcoming Stock of the Month podcast, going live in the MyWallSt app on Monday, August 10. Sign up for your free trial here — https://www.media.mywallst.com/desktop
MyWallSt operates a full disclosure policy. MyWallSt staff may hold long positions in some of the companies mentioned in this podcast.
--- Send in a voice message: https://anchor.fm/stock-club/messageHosted on Acast. See acast.com/privacy for more information.
